Price target upside
Ligand Pharmaceuticals Incorporated Price Target: +16.8% vs Current Price
LGND target gap is +16.8% from $294.60 to $344.10. As of 2026-08-15.
Direct answer
Ligand Pharmaceuticals Incorporated's analyst target implies +16.8%.
The average target is $344.10 compared with a recorded current price of $294.60.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 15, 2026.
Get free Ligand Pharmaceuticals Incorporated email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $294.60
- Average price target
- $344.10
- High price target
- $390.00
- Low price target
- $247.00
- Low target gap
- -16.2%
- Target upside
- +16.8%
- High target gap
- +32.4%
- Target range width
- 48.5%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- August 15, 2026
- Valid through
- August 22, 2026